About Alivora
Pain Management
Chronic pain is a pervasive and often debilitating condition that affects millions and diminishes overall quality of life. At Alivora Therapeutics, we are pioneering cannabinoid-based therapies that target pain at its neurological roots—providing a natural, evidence-based alternative to opioids and other conventional treatments.
Our research is focused on advancing treatment for:
- Neuropathic pain
- Inflammatory pain
- Pain associated with neurodegenerative diseases
With pharmaceutical-grade cannabinoid formulations, we are committed to delivering safe, consistent, and clinically validated relief—supported by rigorous trials and regulatory compliance to ensure the highest standards in patient care.
Multiple Sclerosis (MS)
Multiple Sclerosis is a potentially disabling disease of the brain and spinal cord in which the immune system attacks the protective myelin sheath of nerves. Symptoms range widely but can include fatigue, difficulty walking, pain, vision loss, and spasticity.
Though there is no cure, early treatment can help manage symptoms and slow progression. Alivora’s softgel capsule formulation is designed to address symptoms like spasticity and inflammation in MS.